9th April 2021  Content supplied by: Clent Life Science

Skip Extraction of SARS-CoV-2 with MicroLYSIS-RNA


If you’re using swabs or saliva samples for your COVID-19 RT-qPCR testing, then you should be using MicroLYSIS RNA because it is simple, efficient & effective.

Extraction using columns or beads has been considered the method for preparing RNA for reverse transcription and PCR amplification of SARS-CoV-2, but not anymore...

MicroLYSIS RNA has been shown to quickly and easily release RNA into a buffer that is ready and excellent for reverse transcription and PCR amplification of SARS-CoV-2.

MicroLYSIS RNA is a powerful reagent for use in COVID-19 testing by releasing RT-qPCR ready RNA from a range of samples that include:

  • Dry Swabs
  • Viral Transport Medium
  • Saliva

The resulting lysate is in a ready-to-use format for downstream RT-qPCR testing.

Below we can see results of in-house sensitivity testing of MicroLYSIS RNA. The results are for concentrations of 22, 11, 6, and 3 copies/µl.

2114_Clentlifesciencemicrolysisgra

If you would like further details on MicroLYSIS RNA or any other Clent Life Science products, please use the 'Request Information' button provided below. 


    

Tags:

Date Published: 9th April 2021

Source article link: View


View full company details




Clent Life Science

Address:

Stourbridge

United Kingdom

Tel: 01384 444585

Email Supplier

View full company details